Merck Not Happy With The Billions It Makes Off HPV Vaxx Already: Enlists Oncology Group For More Market Penetration

Merck Not Happy With The Billions It Makes Off HPV Vaxx Already: Enlists Oncology Group For More Market Penetration
The ASCO also called for promoting or even bundling the HPV vaccine with other adolescent vaccines and asked that doctors provide favorable recommendations of HPV vaccines. All this news comes in the week that Julie Gerberding, the former head of the CDC from 2002-2009 when Gardasil was going through its hasty and demonstrably sloppy approval process, just cashed in half of her Merck stock to the tune of $2 million. She is now executive vice president of the company.